Excel Venture Management
VC Fund
Boston, United States
Excel Venture Management is a VC fund in Boston focused on Health Care and Biotechnology. Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond. The Excel investment portfolio is balanced across healthcare IT and services, diagnostics, and medical devices, plus life science platforms that address adjacent markets including energy, chemicals, defense andagriculture. The majority of the team’s prior investments, which include some of the world’s premier healthcare and life science companies, are thriving and over half have achieved successful exits generating billions in value.Excel Venture Management is a spin-off of CB Health Ventures.
- Total investments:
- 66
- Last investment:
- Lead investor:
- 33%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Excel Venture Management invests in
Stages Excel Venture Management invests in
Countries Excel Venture Management invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Rick Blume
|
|||
Caleb Winder
|
|||
Donald M. Crothers
|
|||
Jeanne Henry
|
|||
Juan Enriquez
|
Investment Focus
Industry
- Health Care 30 (45%)
- Biotechnology 20 (30%)
- Medical 12 (18%)
- Software 7 (11%)
- Medical Device 7 (11%)
Stage
- Series B 14 (21%)
- Funding Round 14 (21%)
- Series C 10 (15%)
- Series A 9 (14%)
- Series D 4 (6%)
Country
- United States 43 (65%)
- Canada 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Rick Blume
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
|
Caleb Winder
Managing Director; Director
|
Managing Director; Director | Total investments: 16 | Find email | |
|
Donald M. Crothers
Venture Partner
|
Venture Partner | Total investments: 3 | Find email | |
|
Jeanne Henry
CFO
|
CFO | Total investments: 0 | Find email | |
|
Juan Enriquez
Managing Director
|
Managing Director | Total investments: 8 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
InfoBionic
|
InfoBionic transforms the efficiency and the economics of ambulatory remote patient monitoring processes and cardiac diagnostic services by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. It has developed the MoMe System, a remote patient monitoring platform initially focused on cardiacarrhythmia detection, to improve clinical efficiency and patient care with any time, anywhere access to patient data. The company was founded in 2011 and is headquartered in Waltham, Massachusetts. | $57.8M / Series D / Oct 16, 2023 | |
Orionis Biosciences
|
Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation.The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initialinternal focus in oncology and immunotherapies.Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution. | Private Equity / Jan 01, 2021 | |
Ayogo Health
|
Ayogo is a global leader in the application of behavioral psychology and social gaming to improve health outcomes for patients. Healthier patients improve financial outcomes. Insurers, healthcare providers, ACOs and pharmaceutical companies are Ayogo’s clients. All of our projects begin with meaningful collaboration with patients, end-users andclients. Our corporate culture fosters excellence and thoughtful creation. We maintain the open culture of a startup at our studio in Vancouver’s Centre for Digital Media where our software engineers, user-experience designers, artists and other experts in patient engagement work together. | $7.5M / Series B / May 01, 2020 | |
Gemphire Therapeutics
|
Gemphire Therapeutics manufactures and markets Gemcabene, an LDL cholesterol-lowering medication. It is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH. The company was founded in 2014 and is based in Northville, Michigan. | Private Equity / Jan 01, 2020 | |
Neosensory
|
Neosensory focus on sending a variety of data streams to the brain via the sense of touch. With so much unused real estate on the body, the skin presents huge potential for the delivery of new information. They are currently building the world’s first hearing assistive technology that enables people to listen with their skin. | $10M / Series A / Jan 09, 2019 | |
Openwater
|
Openwater is developing a new generation of imaging technologies, with high resolution and low costs, enabling medical diagnoses and treatments, and a new era of fluid and affordable brain-to-computer communications | $22M / Series A / Dec 10, 2018 | |
ClearDATA
|
Healthcare professionals across the globe trust the ClearDATA HITRUST-certified cloud to safeguard their sensitive data and power their critical applications available across the major public cloud platforms. For healthcare organizations, customers receive one of the most comprehensive Business Associate Agreements (BAA) in the industry, combinedwith market-leading healthcare-exclusive security and compliance solutions, and multi-cloud expertise. ClearDATA’s innovative platform of solutions and services protects customers from data privacy risks, improves their data management, and scales their healthcare IT infrastructure, enabling the industry to focus on making healthcare better by improving healthcare delivery, every single day. | $26M / Series E / Nov 19, 2018 | |
|
InfoBionic
|
InfoBionic transforms the efficiency and the economics of ambulatory remote patient monitoring processes and cardiac diagnostic services by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. It has developed the MoMe System, a remote patient monitoring platform initially focused on cardiacarrhythmia detection, to improve clinical efficiency and patient care with any time, anywhere access to patient data. The company was founded in 2011 and is headquartered in Waltham, Massachusetts. | Sep 12, 2018 | |
|
Openwater
|
Openwater is developing a new generation of imaging technologies, with high resolution and low costs, enabling medical diagnoses and treatments, and a new era of fluid and affordable brain-to-computer communications | Seed / Mar 01, 2018 | |
|
ClearDATA
|
Healthcare professionals across the globe trust the ClearDATA HITRUST-certified cloud to safeguard their sensitive data and power their critical applications available across the major public cloud platforms. For healthcare organizations, customers receive one of the most comprehensive Business Associate Agreements (BAA) in the industry, combinedwith market-leading healthcare-exclusive security and compliance solutions, and multi-cloud expertise. ClearDATA’s innovative platform of solutions and services protects customers from data privacy risks, improves their data management, and scales their healthcare IT infrastructure, enabling the industry to focus on making healthcare better by improving healthcare delivery, every single day. | Series D / Mar 30, 2017 | |
| See all 66 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Excel Venture Management invest in?
Excel Venture Management invests primarily in Health Care, Biotechnology and Medical startups, most often at Series B and Funding Round stage. Most of the 66 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Excel Venture Management?
Public channels for Excel Venture Management include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Excel Venture Management?
The team at Excel Venture Management includes Rick Blume (Managing Director), Caleb Winder (Managing Director; Director) and Donald M. Crothers (Venture Partner), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
